Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antimicrobial use, drug-resistant infections and COVID-19
Timothy M. Rawson, Damien Ming, Raheelah Ahmad, et al.
Nature Reviews Microbiology (2020) Vol. 18, Iss. 8, pp. 409-410
Open Access | Times Cited: 255

Showing 1-25 of 255 citing articles:

Towards the sustainable discovery and development of new antibiotics
Marcus Miethke, Marco Pieroni, Tilmann Weber, et al.
Nature Reviews Chemistry (2021) Vol. 5, Iss. 10, pp. 726-749
Open Access | Times Cited: 791
Antimicrobial resistance and COVID-19: Intersections and implications
Gwenan M. Knight, R. E. Glover, Christopher Finn McQuaid, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 285
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings
Mentor Ali Ber Lucien, Michael F. Canarie, Paul E. Kilgore, et al.
International Journal of Infectious Diseases (2021) Vol. 104, pp. 250-254
Open Access | Times Cited: 224
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study
Fermín Sánchez‐Guijo, Mariano García‐Arranz, Miriam López-Parra, et al.
EClinicalMedicine (2020) Vol. 25, pp. 100454-100454
Open Access | Times Cited: 161
Environmental side effects of the injudicious use of antimicrobials in the era of COVID-19
Muhammad Usman, Muhammad Farooq, Khalil Hanna
The Science of The Total Environment (2020) Vol. 745, pp. 141053-141053
Open Access | Times Cited: 145
The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome
B. Brett Finlay, Katherine R. Amato, Meghan B. Azad, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 6
Open Access | Times Cited: 143
Understanding the role of bacterial and fungal infection in COVID-19
Timothy M. Rawson, Richard Wilson, Alison Holmes
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 9-11
Open Access | Times Cited: 141
Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
Haibo Wang, Minji Wang, Xiaohan Xu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 139
Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions
Saswat S. Mohapatra, Sambit K. Dwibedy, Indira Padhy
Journal of Biosciences (2021) Vol. 46, Iss. 3
Open Access | Times Cited: 139
Lateral flow test engineering and lessons learned from COVID-19
Jobie Budd, Benjamin S. Miller, Nicole E. Weckman, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 1, pp. 13-31
Open Access | Times Cited: 135
An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach
Alvin Qijia Chua, Monica Verma, Li Yang Hsu, et al.
The Lancet Regional Health - Western Pacific (2021) Vol. 7, pp. 100084-100084
Open Access | Times Cited: 126
C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19
Isabell Pink, David Raupach, Jan Fuge, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 935-943
Open Access | Times Cited: 105
Impact of COVID-19 on Antimicrobial Consumption and Spread of Multidrug-Resistance in Bacterial Infections
Kibum Jeon, Seri Jeong, Nuri Lee, et al.
Antibiotics (2022) Vol. 11, Iss. 4, pp. 535-535
Open Access | Times Cited: 73
Increasing Consumption of Antibiotics during the COVID-19 Pandemic: Implications for Patient Health and Emerging Anti-Microbial Resistance
Shahana Seher Malik, Sunil Mundra
Antibiotics (2022) Vol. 12, Iss. 1, pp. 45-45
Open Access | Times Cited: 73
Using Machine Learning to Predict Antimicrobial Resistance―A Literature Review
Aikaterini Sakagianni, Christina Koufopoulou, Georgios Feretzakis, et al.
Antibiotics (2023) Vol. 12, Iss. 3, pp. 452-452
Open Access | Times Cited: 65
Dual Role of Baimao-Longdan-Congrong-Fang in Inhibiting Staphylococcus aureus Virulence Factors and Regulating TNF-α/TNFR1/NF-κB/MMP9 Axis
Tao Jiang, Xingxin Zhu, Zixin Yin, et al.
Phytomedicine (2025) Vol. 139, pp. 156477-156477
Closed Access | Times Cited: 1
Clustered Regularly Interspaced Short Palindromic Repeats-Mediated Surface-Enhanced Raman Scattering Assay for Multidrug-Resistant Bacteria
Hongki Kim, Soohyun Lee, Hwi Won Seo, et al.
ACS Nano (2020) Vol. 14, Iss. 12, pp. 17241-17253
Closed Access | Times Cited: 119
Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic
Rafael Cantón, Desirèe Gijón, Patricia Ruíz-Garbajosa
Current Opinion in Critical Care (2020) Vol. 26, Iss. 5, pp. 433-441
Open Access | Times Cited: 106
Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID
Jorge Calderón‐Parra, A. Muiño-Míguez, Alejandro David Bendala Estrada, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251340-e0251340
Open Access | Times Cited: 100
Antimicrobial Resistance as a Hidden Menace Lurking Behind the COVID-19 Outbreak: The Global Impacts of Too Much Hygiene on AMR
Sama Rezasoltani, Abbas Yadegar, Behzad Hatami, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 92
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance
Jesús Rodríguez‐Baño, Gian María Rossolini, Constance Schultsz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2021) Vol. 115, Iss. 10, pp. 1122-1129
Open Access | Times Cited: 91
Optimising antimicrobial use in humans – review of current evidence and an interdisciplinary consensus on key priorities for research
Esmita Charani, Martin McKee, Raheelah Ahmad, et al.
The Lancet Regional Health - Europe (2021) Vol. 7, pp. 100161-100161
Open Access | Times Cited: 86
Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves
Nina Zhu, Paul Aylin, Timothy M. Rawson, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 5, pp. 762-768
Open Access | Times Cited: 85
Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil
Matheus Polly, Bianca Leal de Almeida, Robert P. Lennon, et al.
American Journal of Infection Control (2021) Vol. 50, Iss. 1, pp. 32-38
Open Access | Times Cited: 85
The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective
Shamshul Ansari, John P. Hays, Andrew H. Kemp, et al.
JAC-Antimicrobial Resistance (2021) Vol. 3, Iss. 2
Open Access | Times Cited: 79
Page 1 - Next Page

Scroll to top